We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
It is a cancer found in the bones and soft tissue. Ewing's sarcoma is the second most common cancer in children, and normally occurs between ten and twenty years old. It is also more common in males than in females. Ewing's sarcoma and primitive neuroectodermal tumours (PNET) are cancers encompassing different types of malignant tumours that share a common chromosomic abnormality. Ewing’s tumours are made up of small undifferentiated cells and tend to be most commonly found in the long bones of the leg or arm, in the flat bones of the ribs and pelvis, or in the spine. They may also occur in any other bone or in soft tissue.
Ewing's tumours located in soft tissue are called extraskeletal Ewing’s sarcoma. They tend to be found in the thigh, pelvis, parts of the spine, the chest wall and the foot.
Primitive neuroectodermal tumours in bones and soft tissue are the least common type of Ewing’s sarcoma. They are made up of immature nerve cells.
The most common symptoms of Ewing’s sarcoma are:
There may also be a lump or swelling around the affected bone or tissue. During diagnosis it is very common to discover a pathological fracture (a non-traumatic fracture) due the fact that the tumour has weakened the bone. Weight loss and fever are other very common symptoms of this kind of tumour.
Malignant neoplasms in children and teenagers are rare, but they are one of the most important causes of morbidity and mortality in these age groups. Ewing’s sarcoma represents 3 % of cancers diagnosed in children throughout Spain. Every year there are around 30 new cases in children under 14 years of age.
If a child shows symptoms of this sarcoma, the doctor will carry out several diagnostic tests which may include:
These tests will help to determine the size and location of the tumour and whether it has spread to other parts of the body.
Three kinds of treatment are often used to treat Ewing’s tumours. Chemotherapy is always used. In addition, surgery (whether to save or amputate the limb) and radiotherapy are used for local control of the tumour. The type of treatment depends on the child's age, the location of the tumour and whether it has spread to other parts of the body.
There are currently no measures to prevent this kind of tumour.
Health tips for patients with sarcoma or other musculoskeletal tumours
Paediatric Intensive Care
Pharmacy
Gynaecological Endoscopic Surgery
Nutritional Support
Preventive Medicine and Epidemiology
Paediatric Ophthalmology
Immunology
Diabetes and Pregnancy Unit
Transplant Coordination
Cardiac Surgery
Physics and Radiation Protection
Paediatric Endocrinology
Clinical Laboratories
Microbiology
Paediatric Oncology and Haematology
Paediatric Hospitalisation and Hospital Paediatrics Unit
Gynaecological Endocrinology
Inherited Heart Disease
Pathological anatomy
General and Digestive Surgery
Gastroenterology, Hepatology, Nutritional Support and Paediatric Hepatic Transplants
Gynaecology
Spinal Cord Injuries
Paediatric Nephrology
Paediatrics
Paediatric emergency care
Paediatric and Adolescent Gynaecology
Bone Metabolism Unit
Neonatology
Hepatobiliary and Pancreatic Surgery and Transplants
Gynaecological Oncology and Pathology of the Lower Genital Tract
Diagnostic and Interventional Haemodynamics
Rheumatology
Neurosurgery
Clinical and molecular genetics
Paediatric Surgery
Prematurity Prevention Unit
Inflammation and Autoimmunity Unit
Anaesthesia, Resuscitation and Pain Management
Paediatric Maxillofacial Surgery
Paediatric Cardiac Surgery
Paediatric Urology
Breast Pathology
Clinical Neurophysiology
Dermatology
Paediatric Oncological Surgery Unit
Foetal Medicine and Surgery Unit
Paediatric Rheumatology Unit
Arrhythmia Unit
Neonatal and Foetal Surgery
Paediatric Orthopaedic Surgery
Traumatology, Rehabilitation and Burns Emergency Care
Paediatric Infectious Diseases and Immunodeficiencies Unit
Tobacco cessation (quitting smoking)
Pneumology, allergology and cystic fibrosis
Hereditary Angioedema Unit
Obstetrics and Reproductive Medicine
Musculoskeletal Techniques and Ultrasound Unit
Biochemistry
Plastic Surgery and Burns
Paediatric Digestive Surgery and Transplants
Obstetric and Gynaecological Emergency Care
Foetal Medicine
Congenital Heart Disease in Adolescents and Adults
Radiodiagnosis (IDI)
Obstetrics Ultrasound Unit
Social Obstetrics Unit
Paediatric Cardiology
Traumatology Intensive Care
Endocrine, Metabolic, and Bariatric Surgery
Sleep Unit
Physical Medicine and Rehabilitation
Paediatric Neurology
Clinical Pharmacology
Prenatal Diagnosis Unit
Perinatal Mental Health Unit
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vhebron.net, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.